Cot kinase activates tumor necrosis factor-α gene expression in a cyclosporin A-resistant manner

被引:42
作者
Ballester, A [1 ]
Velasco, A [1 ]
Tobeña, R [1 ]
Alemany, S [1 ]
机构
[1] Univ Autonoma Madrid, Inst Invest Biomed, CSIC, Fac Med, Madrid, Spain
关键词
D O I
10.1074/jbc.273.23.14099
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cot kinase is a protein serine/threonine kinase, classified as a mitogen-activated protein kinase kinase kinase, implicated in T lymphocyte activation. Here we show that an increase in Cot kinase expression promotes tumor necrosis factor-alpha (TNF-alpha) production in Jurkat T cells stimulated by soluble anti-CD3 or by low concentrations of phorbol 12,13-dibutyrate (PDBu) and calcium ionophore. Overexpression of Cot kinase in Jurkat cells activates TNF-alpha gene expression. Cot kinase promotes TNF-alpha promoter activation to a similar extent as calcium ionophore and PDBu or soluble anti-CD28 and PDBu. Neither phorbol esters nor calcium ionophore can replace Cot kinase on TNF-alpha promoter driven transcription. Expression of a dominant negative form of Cot kinase inhibits TNF-alpha promoter activation induced by stimulation with either calcium ionophore and PDBu, soluble anti-CD28 and PDBu, or soluble anti-CDS and PDBu. TNF-alpha promoter-driven transcription by Cot kinase is partially mediated by MAPK/ERK kinase and is cyclosporin A-resistant. Cot kinase increases at least the AP-1 and AP-2 response elements. These data indicate that Cot kinase plays a critical role in TNF-alpha production.
引用
收藏
页码:14099 / 14106
页数:8
相关论文
共 57 条
[1]  
AOKI M, 1991, ONCOGENE, V6, P1515
[2]  
AOKI M, 1993, J BIOL CHEM, V268, P22723
[3]   INDUCTION OF TYROSINE PHOSPHORYLATION DURING ICAM-3 AND LFA-1-MEDIATED INTERCELLULAR-ADHESION, AND ITS REGULATION BY THE CD45 TYROSINE PHOSPHATASE [J].
ARROYO, AG ;
CAMPANERO, MR ;
SANCHEZMATEOS, P ;
ZAPATA, JM ;
URSA, MA ;
DELPOZO, MA ;
SANCHEZMADRID, F .
JOURNAL OF CELL BIOLOGY, 1994, 126 (05) :1277-1286
[4]  
Ballester A, 1997, J IMMUNOL, V159, P1613
[5]  
BAUMGARTNER RA, 1994, J IMMUNOL, V153, P2609
[6]   Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation [J].
Ceci, JD ;
Patriotis, CP ;
Tsatsanis, C ;
Makris, AM ;
Kovatch, R ;
Swing, DA ;
Jenkins, NA ;
Tsichlis, PN ;
Copeland, NG .
GENES & DEVELOPMENT, 1997, 11 (06) :688-700
[7]  
CHAN AML, 1993, ONCOGENE, V8, P1329
[8]   REGULATION OF TUMOR NECROSIS FACTOR-ALPHA TRANSCRIPTION IN MACROPHAGES - INVOLVEMENT OF 4 KAPPA-B-LIKE MOTIFS AND OF CONSTITUTIVE AND INDUCIBLE FORMS OF NF-KAPPA-B [J].
COLLART, MA ;
BAEUERLE, P ;
VASSALLI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1498-1506
[9]  
CORREALE J, 1995, J IMMUNOL, V154, P2959
[10]   INDEPENDENT REGULATION OF TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN PRODUCTION BY HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
CUTURI, MC ;
MURPHY, M ;
COSTAGIOMI, MP ;
WEINMANN, R ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1581-1594